Evidence map›Paper›PMID 37578957›Full record

ArticlePLoS pathogens2023

The phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells.

Jana Koch, Qilin Xin, Martin Obr, Alicia Schäfer, Nina Rolfs, Holda A Anagho, Aiste Kudulyte, Lea Woltereck, Susann Kummer, Joaquin Campos and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. An Introduction to Rift Valley Fever Virus.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 5 countries.

Jana KochCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-3574-0805
Qilin XinUniv. Lyon, INRAE, EPHE, IVPC, Lyon, France.ORCID 0000-0002-1087-2422
Martin ObrInstitute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.ORCID 0000-0003-1756-6564
Alicia SchäferCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.
Nina RolfsCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.
Holda A AnaghoCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-6406-161X
Aiste KudulyteCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.
Lea WoltereckCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.
Susann KummerCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-1010-9889
Joaquin CamposChica and Heinz Schaller Research Group, Institute of Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.
Zina M UckeleyCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-9770-9873
Lesley Bell-SakyiInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United-Kingdom.ORCID 0000-0002-7305-0477
Hans-Georg KräusslichCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-8756-329X
Florian Km SchurInstitute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.
Claudio AcunaChica and Heinz Schaller Research Group, Institute of Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-8849-6260
Pierre-Yves LozachCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-9966-1452
Heidelberg University · DEUniversité Claude Bernard Lyon 1 · FRInstitute of Science and Technology Austria · ATUniversity of Liverpool · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P024270/1Wellcome TrustWellcome Trust 223743/Z/21/Z
6 · The paper itself

Abstract

Toscana virus is a major cause of arboviral disease in humans in the Mediterranean basin during summer. However, early virus-host cell interactions and entry mechanisms remain poorly characterized. Investigating iPSC-derived human neurons and cell lines, we found that virus binding to the cell surface was specific, and 50% of bound virions were endocytosed within 10 min. Virions entered Rab5a+ early endosomes and, subsequently, Rab7a+ and LAMP-1+ late endosomal compartments. Penetration required intact late endosomes and occurred within 30 min following internalization. Virus entry relied on vacuolar acidification, with an optimal pH for viral membrane fusion at pH 5.5. The pH threshold increased to 5.8 with longer pre-exposure of virions to the slightly acidic pH in early endosomes. Strikingly, the particles remained infectious after entering late endosomes with a pH below the fusion threshold. Overall, our study establishes Toscana virus as a late-penetrating virus and reveals an atypical use of vacuolar acidity by this virus to enter host cells.

Indexed as

Sandfly fever Naples virusEndocytosisEndosomesHumansHydrogen-Ion ConcentrationVacuolesVirus Internalization

Identifiers

PMID37578957
PMCPMC10449198
OpenAlexW4385802069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.